Home › Therapeutic areas › Infectious Disease › Nontuberculous Mycobacterial Lung Disease

Nontuberculous Mycobacterial Lung Disease (1 companies)

Companies with an active program in Nontuberculous Mycobacterial Lung Disease.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
INSM	Insmed	CardiovascularImmunology+3 Rare	1	Approved	$25.1B	15